Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production

Vaccine

Volumn 28, Issue 5, 2010, Pages 1285-1293

  Liu, Jonathan ^a   Mani, Sachin ^a   Schwartz, Richard ^a   Richman, Laura ^a   Tabor, David E ^a  

^a MedImmune   (United States)

Author keywords

Cell cloning; Influenza vaccine; MDCK; Oncogenicity; Tumorigenicity

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CLONING; CELL CULTURE; CELL LINE; CELL POPULATION; CELL STRAIN; CELL TRANSFORMATION; CONTROLLED STUDY; DILUTION; FEMALE; HAMSTER; INJECTION; KIDNEY CELL; MALE; MOUSE; NEWBORN; NONHUMAN; NUDE MOUSE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RAT; SAFETY; VACCINE PRODUCTION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; DOGS; HUMANS; INFLUENZA VACCINES; MICE; MICE, NUDE; RATS;

EID: 74149091825     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.023     Document Type: Article

References (56)

1. Beyer W.E., de Bruijn I.A., Palache A.M., Westendorp R.G., and Osterhaus A.D. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med 159 January (2) (1999) 182-188
2. Kieny M.P., Costa A., Hombach J., Carrasco P., Pervikov Y., Salisbury D., et al. A global pandemic influenza vaccine action plan. Vaccine 24 September (40-41) (2006) 6367-6370
3. Anonymous. Influenza virus vaccine live intranasal-MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D 4 5 (2003) 312-319
4. Belshe R.B., and Mendelman P.M. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. Immunol Allergy Clin North Am 23 November (4) (2003) 745-767
5. Madin S.H., and Darby Jr. N.B. Established kidney cell lines of normal adult bovine and ovine origin. Proc Soc Exp Biol Med 98 July (3) (1958) 574-576
6. Frank A.L. Selected laboratory aspects of influenza surveillance. Yale J Biol Med 55 May-August (3-4) (1982) 201-205
7. Mills R.D., Cain K.J., and Woods G.L. Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies. J Clin Microbiol 27 November (11) (1989) 2505-2508
8. Ziegler T., Hall H., Sanchez-Fauquier A., Gamble W.C., and Cox N.J. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol 33 February (2) (1995) 318-321
9. Gaush C.R., Hard W.L., and Smith T.F. Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med 122 July (3) (1966) 931-935
10. Baez M., Palese P., and Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141 March (3) (1980) 362-365
11. Liu J., Shi X., Schwartz R., and Kemble G. Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 27 October (46) (2009) 6460-6463
12. Reed L.J., and Muench H. A simple method of estimation fifty per cent endpoints. Am J Hyg 27 (1938) 5
13. Wei Z., McEvoy M., Razinkov V., Polozova A., Li E., Casas-Finet J., et al. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity. J Virol Methods 144 September (1-2) (2007) 122-132
14. FDA. Draft points to consider in the characterization of cell lines used to produce biologicals; 1993.
15. FDA. Guidance for industry: characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases. Biotechnology Law Report 2006;25(6):697-723.
16. Ledwith B.J., Lanning C.L., Gumprecht L.A., Anderson C.A., Coleman J.B., Gatto N.T., et al. Tumorigenicity assessments of Per. C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Dev Biol (Basel) 123 (2006) 251-263 [discussion 65-6]
17. Henriques U. Histological technique in routine histopathology. An opinion. Pathol Res Pract 171 May (3-4) (1981) 417-422
18. Tuson J.R., Pascoe E.W., and Jacob D.A. A novel immunohistochemical technique for demonstration of specific binding of human monoclonal antibodies to human cryostat tissue sections. J Histochem Cytochem 38 July (7) (1990) 923-926
19. Fung K.M., Messing A., Lee V.M., and Trojanowski J.Q. A novel modification of the avidin-biotin complex method for immunohistochemical studies of transgenic mice with murine monoclonal antibodies. J Histochem Cytochem 40 September (9) (1992) 1319-1328
20. Hierck B.P., Iperen L.V., Gittenberger-De Groot A.C., and Poelmann R.E. Modified indirect immunodetection allows study of murine tissue with mouse monoclonal antibodies. J Histochem Cytochem 42 November (11) (1994) 1499-1502
21. Walker J.A., Hughes D.A., Hedges D.J., Anders B.A., Laborde M.E., Shewale J., et al. Quantitative PCR for DNA identification based on genome-specific interspersed repetitive elements. Genomics 83 March (3) (2004) 518-527
22. Maita K., Hirano M., Harada T., Mitsumori K., Yoshida A., Takahashi K., et al. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol 16 3 (1988) 340-349
23. Frith C.H., Ward J.M., and Chandra M. The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol 21 2 (1993) 206-218
24. Son W.C., and Gopinath C. Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats. Toxicol Pathol 32 July-August (4) (2004) 371-374
25. Sheng L., Cai F., Zhu Y., Pal A., Athanasiou M., Orrison B., et al. Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc. Biologicals 36 May (3) (2008) 184-197
26. Braun L., Goyette M., Yaswen P., Thompson N.L., and Fausto N. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res 47 August (15) (1987) 4116-4124
27. Haseman J.K., Hailey J.R., and Morris R.W. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 26 May-June (3) (1998) 428-441
28. Poteracki J., and Walsh K.M. Spontaneous neoplasms in control Wistar rats: a comparison of reviews. Toxicol Sci 45 September (1) (1998) 1-8
29. Zwicker G.M., Eyster R.C., Sells D.M., and Gass J.H. Spontaneous vascular neoplasms in aged Sprague-Dawley rats. Toxicol Pathol 23 July-August (4) (1995) 518-526
30. Pour P., Mohr U., Althoff J., Cardesa A., and Kmoch N. Spontaneous tumors and common diseases in two colonies of Syrian hamsters. III. Urogenital system and endocrine glands. J Natl Cancer Inst 56 May (5) (1976) 949-961
31. Fedson D.S. Vaccination for pandemic influenza: a six point agenda for interpandemic years. Pediatr Infect Dis J 23 January (Suppl. 1) (2004) S74-S77
32. Mabrouk T., and Ellis R.W. Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine). Dev Biol (Basel) 110 (2002) 125-134
33. FDA. Complete list of vaccines licensed for immunization and distribution in the US (2009), US Food and Drug Administration
34. Barrett P.N., Mundt W., Kistner O., and Howard M.K. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines 8 May (5) (2009) 607-618
35. Monath T.P., Caldwell J.R., Mundt W., Fusco J., Johnson C.S., Buller M., et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense. Int J Infect Dis October (8 Suppl. 2) (2004) S31-S44
36. Weltzin R., Liu J., Pugachev K.V., Myers G.A., Coughlin B., Blum P.S., et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med 9 September (9) (2003) 1125-1130
37. Manohar M., Orrison B., Peden K., and Lewis Jr. A.M. Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice. Biologicals 36 January (1) (2008) 65-72
38. Romanova J., Katinger D., Ferko B., Vcelar B., Sereinig S., Kuznetsov O., et al. Live cold-adapted influenza A vaccine produced in Vero cell line. Virus Res 103 July (1-2) (2004) 187-193
39. Grondahl F., Tveit H., and Prydz K. Neutralization of endomembrane compartments in epithelial MDCK cells affects proteoglycan synthesis in the apical secretory pathway. Biochem J 418 March (3) (2009) 517-528
40. Wahl A., Sidorenko Y., Dauner M., Genzel Y., and Reichl U. Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution. Biotechnol Bioeng 101 September (1) (2008) 135-152
41. Oh D.Y., Barr I.G., Mosse J.A., and Laurie K.L. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol 46 July (7) (2008) 2189-2194
42. Fujii H., Takahashi H., Ohyama T., Hattori K., and Suzuki S. Evaluation of the school health surveillance system for influenza, Tokyo, 1999-2000. Jpn J Infect Dis 55 June (3) (2002) 97-99
43. Leighton J., Brada Z., Estes L.W., and Justh G. Secretory activity and oncogenicity of a cell line (MDCK) derived from canine kidney. Science 163 January (866) (1969) 472-473
44. Leighton J., Estes L.W., Mansukhani S., and Brada Z. A cell line derived from normal dog kidney (MDCK) exhibiting qualities of papillary adenocarcinoma and of renal tubular epithelium. Cancer 26 November (5) (1970) 1022-1028
45. Stiles C.D., Desmond W., Chuman L.M., Sato G., and Saier Jr. M.H. Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice. Cancer Res 36 September (9 pt. 1) (1976) 3300-3305
46. Barker G., and Simmons N.L. Identification of two strains of cultured canine renal epithelial cells (MDCK cells) which display entirely different physiological properties. Q J Exp Physiol 66 January (1) (1981) 61-72
47. Meier K.E., Snavely M.D., Brown S.L., Brown J.H., and Insel P.A. Alpha 1- and beta 2-adrenergic receptor expression in the Madin-Darby canine kidney epithelial cell line. J Cell Biol 97 August (2) (1983) 405-415
48. Nakazato Y., Suzuki H., and Saruta T. Characterization of subclones of Madin-Darby canine kidney renal epithelial cell line. Biochim Biophys Acta 1014 October (1) (1989) 57-65
49. Medema J.K., Meijer J., Kersten A.J., and Horton R. Safety assessment of Madin Darby canine kidney cells as vaccine substrate. Dev Biol (Basel) 123 (2006) 243-250 [discussion 65-6]
50. Percheson P.B., Trepanier P., Dugre R., and Mabrouk T. A Phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line. Dev Biol Stand 98 (1999) 127-132 [discussion 33-4]
51. Merten O.W., Manuguerra J.C., Hannoun C., and van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand 98 (1999) 23-37 [discussion 73-4]
52. Ghendon Y.Z., Markushin S.G., Akopova I.I., Koptiaeva I.B., Nechaeva E.A., Mazurkova L.A., et al. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 23 September (38) (2005) 4678-4684
53. Chiron. Use of MDCK cells for manufacture of inactivated influenza virus vaccines. VRBPAC - 16 Nov 05 - Slides. [pdf file] 2005 [cited 2008 July 30]; final slides presented by Chiron at the November 16 VRBPAC meeting]. Available from: http://www.fda.gov/ohrms/dockets/ac/05/slides/5-4188S1_5.pdf.
54. Shin S.I., Freedman V.H., Risser R., and Pollack R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 72 November (11) (1975) 4435-4439
55. Merlin S., Pietronave S., Locarno D., Valente G., Follenzi A., and Prat M. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene. Cancer Sci 100 April (4) (2009) 633-638
56. Boerner H.S., Rindler M.J., Chuman L., and Saier Jr. M.H. Characterization of chemically and virally transformed variants of Madin-Darby canine kidney (MDCK) epithelial cells. J Cell Physiol 122 February (2) (1985) 299-307